HITLAB

After working for several years as a general pediatrician, I pursued specialized training in both pediatric sleep medicine and pediatric pulmonology. Experience in these three areas helps me understand how the entire body, particularly the respiratory system, is affected by a child’s sleep...

Dana Goldner, MD, is an Assistant Professor of Pediatrics in Pediatric Hepatology at Columbia University Medical Center and an Assistant Attending at NewYork-Presbyterian Morgan Stanley Childrens Hospital. Prior to her faculty appointment, Dr. Goldner earned her Bachelor of Science degree in Biology from the Massachusetts Institute of Technology (MIT). She completed her medical education at Weill Cornell Medical College/NewYork-Presbyterian and subsequently completed her Pediatric Internship and Residency at Massachusetts General Hospital/Harvard Medical School in Boston. She then went on to pursue fellowships in both Pediatric Gastroenterology, Hepatology and Nutrition and Pediatric Transplant Hepatology at New York Presbyterian/Columbia University Medical Center.Dr. Goldner is triple board certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.Her research and clinical interests include liver transplant, biliary atresia, neonatal cholestasis, Alpha-1 antitrypsin deficiency, Genetic/Metabolic liver disease, liver tumors, Alagille Syndrome, autoimmune liver disease, Wilson Disease, hepatoblastoma, and acute liver failure.Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Dr. Erika Berman Rosenzweig, Director of the Pulmonary Hypertension Center at Columbia University Medical Center/NewYork-Presbyterian Hospital and the CTEPH Program at CUMC, is considered an international expert in the field of pulmonary hypertension. She has tremendous clinical and research experience in the fields of adult and pediatric pulmonary hypertension. Dr. Rosenzweig is widely published and has devoted remarkable efforts toward clinical research on the study of novel treatments and genetic causes of pulmonary hypertension as well as novel approaches to mechanical support for patients with end-stage pulmonary hypertension. She has been an active member of the Pulmonary Hypertension Association (PHA) and is currently on the Board of Trustees of the PHA, Immediate past Chair of the Scientific Leadership Council of the PHA, past Chair of the Review Committee for PHCC PH Center Accreditation Program, and past Editor-in Chief of the medical journal Advances in Pulmonary Hypertension. Dr. Rosenzweig was recently appointed to be on the Scientific Board of the World Symposium on PH Association.